Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Seventh Amended and Restated Certificate of Incorporation
- 3.3 Bylaws
- 4.1 Form of Common Stock Certificate
- 4.2 Investors' Rights Agreement
- 4.3 Form of Series C Warrant
- 4.4 Series C-1 Warrant
- 4.5 Series D Warrant
- 4.6 Series E Warrant
- 10.2 2008 Stock Plan
- 10.8 Office Leases
- 10.9 Distribution Agreement (Bader)
- 10.10 Loan and Security Agreement
- 16.1 Consent of Ernst and Young LLP
- 21.1 Subsidiary of Registrant
- 23.1 Consent of KPMG LLP
RSLS similar filings
Filing view
External links
Exhibit 16.1
August 4, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Obalon Therapeutics, Inc.’s statements included under the caption “Change in Accountants” in its Form S-1 filed on August 4, 2016, and are in agreement with the statements contained in the second paragraph and the first sentence of the fourth paragraph within this caption. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP